2種のβラクタマーゼを有するE .coliの分子生物学的性質を解析

Შ ᆔƷ‚ȩǯǿȞȸǼǛஊƢǔ ‷†⁕⁡⁞⁛ Ʒ
Ў‫܇‬ဃཋ‫ܖ‬ႎࣱឋǛᚐௌ
٤ ቝ੗ ቁῺ ᄹ⦟⋵┙ක⑼ᄢቇ㒝ዻ∛㒮
ਛጊ ┨ᢥ ᄹ⦟⋵┙ක⑼ᄢቇ㒝ዻ∛㒮㧔⃻ ጘ㒂ක≮⑼ቇᄢቇ଻ஜ⑼ቇㇱ⥃ᐥᬌᩏቇ⑼㧕
⮮ᧄ ⢒ሶ ᄹ⦟⋵┙ක⑼ᄢቇ㒝ዻ∛㒮
㧨⎇ⓥ⋡⊛㧪
ㄭᐕ Extended spectrum--Lactamase㧔ESBL㧕޽ࠆ޿ߪ Metallo--Lactamase㧔MBL㧕ࠍ↥↢ߔࠆ
᭽‫ࡓ࡜ࠣߩࡊࠗ࠲ߥޘ‬㒶ᕈ᪝⩶߇࿖ౝᄖߢჇടߒߡ߅ࠅ㧘ᐢၞ -࡜ࠢ࠲ࡓ⮎߳ߩ⠴ᕈൻ߇ᷓೞ
ߥක≮໧㗴ߣߥߞߡ޿ࠆ㧚ᧄቇ㒝ዻ∛㒮ߦߡ㧘ߎߩਔᣇߩǪ࡜ࠢ࠲ࡑ࡯࠯ࠍ↥↢ߔࠆ Escherichia
coli ߇ᬌ಴ߐࠇ㧘ߎࠇࠄ 2 ⒳㘃ߩ⠴ᕈㆮવሶ߇ Plasmid ߦࠦ࡯࠼ߐࠇߡ޿ࠆߎߣߩ⏕⹺ࠍⴕ޿㧘
ߎߩ Plasmid ߩಽᨆࠍⴕ߁ߎߣࠍ⋡⊛ߣߒߚ㧚
㧨᧚ᢱߣᣇᴺ㧪
1㧚 ૶↪⩶ᩣ
࡮ ESBL ߣ MBL ࠍ↥↢ߔࠆ E. coli㧔⥃ᐥಽ㔌ᩣ E. coli NM5759㧕
࡮ ㆮવሶવ㆐⹜㛎ߩฃኈ⩶ߦ↪޿ߚ E. coli GN42㧔ࠕࠫൻ࠽࠻࡝࠙ࡓ⠴ᕈᩣ㧕
࡮ ᒻ⾰ォ឵ߢ Competent cell ߣߒߡ↪޿ߚ E. coli JM109㧔TOYOBO㧕
2㧚⩶⒳หቯ߅ࠃ߮⮎೷ᗵฃᕈ⹜㛎
ฦ⩶ᩣߩ↢ൻቇ⊛ᕈ⁁⹜㛎߅ࠃ߮⮎೷ᗵฃᕈ⹜㛎ߪ㧘⥄േ᷹ቯᯏེ VITEK 2-XL㧔SYSMEX
bioMerieux ␠㧕ࠍ૶↪ߒ㧘ࡃࠗ࠹࠶ࠢ 2 GN หቯࠞ࡯࠼ߣࡃࠗ࠹࠶ࠢ 2 ࠣ࡜ࡓ㒶ᕈ⩶ᗵฃᕈࠞ
࡯࠼ AST-N125 ࠍ↪޿ߡᷝઃᢥᦠߦᓥ޿ታᣉߒߚ㧚
3㧚ESBL ߅ࠃ߮ MBL ⏕⹺⹜㛎
⹜㛎⩶ᩣ߅ࠃ߮ㆮવሶવ㆐⩶ᩣߩ ESBL ߅ࠃ߮ MBL ↥↢ᕈߩ⏕⹺⹜㛎ߪ㧘Double Disk
synergy test㧔DDST㧕ߦࠃߞߡⴕߞߚ㧚
4㧚ㆮવሶવ㆐⹜㛎
ฃኈ⩶㧔E. coli GN42㧕߅ࠃ߮ଏਈ⩶㧔E. coli NM5759㧕ࠍᷙวၭ㙃ߒߚ㧚⊒⢒ߒߚࠦࡠ࠾
࡯ࠍ 25g/mL ABPC ߣ 1mM ࠕࠫൻ࠽࠻࡝࠙ࡓࠍ฽߻ Luria-Bertani㧔LB㧕ኙᄤၭ࿾ߢၭ㙃ߒߚ㧚
⊒⢒ߒߚࠦࡠ࠾࡯ߦߟ޿ߡ↢ൻቇ⊛ᕈ⁁߅ࠃ߮⮎೷ᗵฃᕈߩ⏕⹺ࠍⴕߞߚ㧚ߥ߅㧘⹜㛎೨ߩฃ
ኈ⩶㧘ଏਈ⩶ࠍߘࠇߙࠇ LB ኙᄤၭ࿾㧔ABPC㧘ࠕࠫൻ࠽࠻࡝࠙ࡓࠍ฽߻㧕ߦߡห᧦ઙߢၭ㙃ߒ㧘
⊒⢒ߒߥ޿ߎߣࠍ⏕⹺ߒߚ㧚
5㧚ࡊ࡜ࠬࡒ࠼ DNA ߩ⺞ᢛ
ࡊ࡜ࠬࡒ࠼♖⵾ࠠ࠶࠻ NucleoBondBAC100 (MACHEREY-NAGEL ␠) ࠍ↪޿ߡᷝઃߩ⺑᣿ᦠ
ߦᓥ޿㧘ࡊ࡜ࠬࡒ࠼ DNA ߩ⺞ᢛࠍⴕߞߚ㧚ࡊ࡜ࠬࡒ࠼ߩ⏕⹺ߪ 0.7㧑ࠕࠟࡠ࡯ࠬࠥ࡞ߦߡ㔚᳇
ᵒേ㧔100V㧘45 ಽ㧕ߒ㧘GelRed㧔Nucleic Acid Gel Stain, 10,000x in Water㧘Biotium㧕ߢ 20 ಽᨴ
㧙 㧙
⦡ᓟ㧘࠻࡜ࡦࠬࠗ࡞ࡒࡀ࡯࠲࡯ߢ⏕⹺ߒߚ㧚
6㧚ᒻ⾰ォ឵ታ㛎
E. coli NM5759 ࠃࠅ♖⵾ߒߚࡊ࡜ࠬࡒ࠼ DNA ࠍ‫ޔ‬E. coli Competent Cell Kit㧔Competent high
JM109㧘TOYOBO㧕ߦኻߒߡᒻ⾰ォ឵ታ㛎ࠍⴕߞߚ㧚
7㧚PCR ᴺߦࠃࠆ ESBL㧘MBL ↥↢ㆮવሶߩ⏕⹺
․⇣ࡊ࡜ࠗࡑ࡯ࠍ↪޿ߚ PCR ᴺߦࠃࠆ⮎೷⠴ᕈㆮવሶ blaCTX-M㧘blaIMP-1 ߩᬌ಴ࠍⴕߞߚ㧚
PCR ෻ᔕᶧߩ⚵ᚑߪ 5˜Green buffer㧧5L㧘 25mM MgCL2㧧2.5L㧘10mM dNTPs㧧0.5L㧘10M
CTX-M-F1(IMP1-F1)㧧1L㧘10M CTX-M-R1(IMP1-R1)㧧1L㧘5units/L GoTaq PCR polymerase㧧
0.25L㧘Ṍ⩶ H2O 12.25L㧘㍌ဳ DNA 2.5L ߢో㊂߇ 25L ߦߥࠆࠃ߁ߦ⺞ᢛߒߚ㧚PCR ߩ෻
ᔕ᧦ઙߪ 94͠㧘2 ಽߩࡊ࡟ࠨࠗࠢ࡞ᓟ㧘94͠ 30 ⑽㧘58͠ 60 ⑽㧘72͠60 ⑽ࠍ 35 ࠨࠗࠢ࡞ⴕ
ߥ޿㧘ᦨᓟߦ 72͠ߢ 3 ಽ㑆෻ᔕߐߖߚ㧚Ⴧ᏷↥‛ߪ 2㧑ࠕࠟࡠ࡯ࠬࠥ࡞㧔Invitrogen Ultrapure
agarose 1200mg in 60mL 1˜TAE buffer + 6L SYBR SAFE DNA stain㧘×10000㧕ߢ㔚᳇ᵒേࠍⴕ޿
⏕⹺ߒߚ㧚
8㧚Ⴎၮ㈩೉ߩ⸃ᨆ
ࡊ࡜ࠬࡒ࠼ p-NM5759-JM ߩႮၮ㈩೉ߩ⸃ᨆߦߪ㧘blaCTX-M㧘blaIMP-1 ߩᬌ಴ߦ૶↪ߒߚ PCR
ࡊ࡜ࠗࡑ࡯ࠍ↪޿ߡ㧘ESBL ߅ࠃ߮ MBL ㆮવሶࠍ⿠ὐߣߒߡႮၮ㈩೉ࠍ⺞ߴߚ㧚Ⴎၮ㈩೉ߩಽ
ᨆߪ㧘Sanger ࠄ 1)ߩᣇᴺߦᓥ޿ࠪ࡯ࠤࡦࠬ෻ᔕߦߪ BigDye terminator v3.1 cycle sequencing kit
ࠍ૶↪ߒ㧘ABI prism 310 genetic analyzer㧔 Applied Biosystems)ߦࠃߞߡಽᨆߒߚ㧚߹ߚ㧘ᓧࠄ
ࠇߚႮၮ㈩೉ߩ⸃ᨆߪ㧘Basic Local Alignment Search Tool (BLAST; http://blast.ncbi.nlm.nih.gov/)
ࠍ↪޿ߡⴕߞߚ㧚
㧨⚿ᨐ㧪
1㧚E. coli NM5759 ߩ ESBL ߅ࠃ߮ MBL ↥↢ᕈ⏕⹺⹜㛎
E. coli NM5759 ߪ ESBL ߅ࠃ߮ MBL ࠍหᤨߦ↥↢ߒߡ޿ࠆߎߣ߇⏕⹺ߐࠇߚ㧚
b
a
CAZ
CPDX
ACV
CFPM
CAZ
CTX
CFPM
SMA
IPM
MEPM
Double Disk synergy test㧔DDST㧕
㧔a㧕 Extended spectrum-Ǫ-lactamase㧔b㧕 Metallo-Ǫ-lactamase
2㧚ㆮવሶવ㆐⹜㛎
ଏਈ⩶ᩣ㧔E. coli NM5759㧕㧘ฃኈ⩶ᩣ㧔E. coli GN42㧕㧘ㆮવሶવ㆐⩶ᩣ㧔E. coli NM5759/GN42㧕
ߩ↢ൻቇ⊛ᕈ⁁㧔⴫ 1㧕߅ࠃ߮㧘⮎೷ᗵฃᕈࡄ࠲࡯ࡦ㧔⴫ 2㧕ࠍᲧセߒߚ㧚↢ൻቇ⊛ᕈ⁁ߪ E. coli
GN42 ߣ E. coli NM5759/GN42 ߦ߅޿ߡቢోߦ৻⥌ߒ㧘⮎೷ᗵฃᕈࡄ࠲࡯ࡦߪᱴߤߩ -࡜ࠢ࠲ࡓ
♽⮎ߦ߅޿ߡ E. coli GN42 ߦᲧߒߡ㧘E. coli NM5759/GN42 ߪ MIC ਄᣹ࠍ⹺߼ߚ㧚
㧙 㧙
⴫ 1.↢ൻቇ⊛ᕈ⁁ߩᲧセ
E. coli NM5759
E. coli GN42
E. coli NM5759/GN42
BGAL䋻Beta-galactosidase
ProA䋻L-Proline arylamidase
(donor)
(recipient)
(transconjugant)
BGAL
㪂
㪄
㪄
ProA
㪄
㪂
㪂
TyrA
㪄
㪂
㪂
SAC䋻saccharose/sucrose
SAC
㪂
㪄
㪄
5KG䋻5-Keto-D-gluconate
5KG
㪄
㪂
㪂
PHOS
㪄
㪂
㪂
ODC
㪂
㪄
㪄
ODC䋻Ornithine Decarboxylase
BGUR
㪂
㪄
㪄
BGUR䋻Beta-glucoronidase
O129R
㪄
㪂
㪂
ELLM
㪄
㪂
㪂
MOT
㪂
㪄
㪄
TyrA䋻Tyrosine arylamidase
PHOS䋻phosphatase
O129R䋻O/129 Resistance
ELLM䋻Ellman
⴫ 2.⮎೷ᗵฃᕈࡄ࠲࡯ࡦߩᲧセ
MIC (㱘g/mL䋩
E. coli NM5759
E. coli GN42
E. coli NM5759/GN42
(donor)
(recipient)
(transconjugant)
Ampicillin
㪕㪔㪊㪉
㪓㪔㪉
㪕㪔㪊㪉
Piperacillin
㪕㪔㪈㪉㪏
㪓㪔㪋
㪕㪔㪈㪉㪏
Amoxicillin/
㪕㪔㪊㪉
㪋
㪈㪍
Cefazolin
㪕㪔㪍㪋
㪓㪔㪋
㪕㪔㪍㪋
Cefmetazole
㪕㪔㪍㪋
㪓㪔㪈
㪊㪉
Cefpodoxime
㪕㪔㪏
㪓㪔㪇㪅㪉㪌
㪕㪔㪏
Cefotaxime
㪕㪔㪍㪋
㪓㪔㪈
㪕㪔㪍㪋
Ceftazidime
㪈㪍
㪓㪔㪈
㪈㪍
Aztreonam
㪕㪔㪍㪋
㪓㪔㪈
㪈㪍
㪋
㪓㪔㪈
㪉
㪓㪔㪈
㪓㪔㪈
㪓㪔㪈
Meropenem
㪈
㪓㪔㪇㪅㪉㪌
㪉
Gentamicin
㪋
㪓㪔㪈
㪓㪔㪈
Levofloxacin
㪕㪔㪏
㪓㪔㪇㪅㪈㪉
㪓㪔㪇㪅㪈㪉
Ciprofloxacin
㪕㪔㪋
㪓㪔㪇㪅㪉㪌
㪓㪔㪇㪅㪉㪌
㪓㪔㪇㪅㪉㪌
clavulanate
Cefepim
Imipenem
3㧚E. coli NM5759 ߩࡊ࡜ࠬࡒ࠼ࡄ࠲࡯ࡦ
ࠨࠗ࠭ߩ⇣ߥࠆ 3 ⒳㘃ߩࡊ࡜ࠬࡒ࠼ߦ⋧ᒰߔࠆߣ⠨߃ࠄࠇࠆ DNA ࡃࡦ࠼߇⏕⹺ߐࠇߚ㧚
㧙 㧙
M 1
( kbp )
Plasmid䉰䉟䉵䈱ᄢ䈐䈇䉅䈱䈎䉌A,B,C䈫䈚䈢
A
19.33
Lane M䋬DNA ladder䋨㱗-Sty I䋩lane 1䋬E. coli NM5759
7.74
6.22
0.7䋦䉝䉧䊨䊷䉴䉭䊦㔚᳇ᵒേ䋨100V䋬45ಽ䋩
4.26
3.47
2.69
B
䊒䊤䉴䊚䊄 DNA䈱⺞ᢛ
C
NucleoBondBAC100 (MACHEREY-NAGEL)
1.88
4㧚ESBL ߅ࠃ߮ MBL ㆮવሶࠍ଻᦭ߔࠆࡊ࡜ࠬࡒ࠼ DNA ߩන㔌
ᦨ߽ࠨࠗ࠭ߩᄢ߈޿ p-NM5759-JM ߩߺࠍ଻᦭ߒ㧘ESBL ߅ࠃ߮ MBL ㆮવሶߩ PCR ߇㓁ᕈࠍ␜
ߔᒻ⾰ォ឵ᩣ߇ᓧࠄࠇߚ㧚
1
2
3
4
5
M
ߩ଻᦭ߔࠆplasmidA䈮⋧ᒰ䈜䉎
A: E. coli NM5759ߩ
Lane 1䋺p-NM5759-JM1䋬lane 2䋺p-NM5759-JM2
A
lane 3䋺p-NM5759-JM3, lane 4䋺p-NM5759-JM4
lane 5䋺p-NM5759䋬lane M䋺DNA ladder䋨2.5Kb䋩
0.9䋦䉝䉧䊨䊷䉴䉭䊦㔚᳇ᵒേ䋨100V䋬45ಽ䋩
5㧚ࡊ࡜ࠬࡒ࠼ p-NM5759-JM ߩಽᨆ
ESBL ㆮવሶࠍ⿠ὐߣߒߚ㈩೉ߢߪ blaCTX-M-2 ߩ᭴ㅧㆮવሶߣߘߩ਄ᵹߦ ccgAII㧘ccgEIII㧘ardR㧘
ardB㧘ਅᵹߦ tnpA ߩႮၮ㈩೉߇⏕⹺ߐࠇߚ㧔ਅ࿑-a㧕㧚ߘߒߡ㧘blaIMP-6 ࠍ⿠ὐߣߒߚ㈩೉ߢߪ
MBL ↥↢ㆮવሶߩ᭴ㅧㆮવሶߣߘߩ਄ᵹߦ intI1㧘aacA4㧘ਅᵹߦ aadA2㧘tnp ߩႮၮ㈩೉߇⏕⹺
ߐࠇߚ㧔ਅ࿑-b㧕㧚
a
b
ccgAII䋻CcgAII regulatory protein䋬ccgEIII 䋻CcgEII regulatory protein䋬ardR䋻ArdR regulatory protein䋬ardB䋻ArdB antirestriction
protein䋬tnpA䋻ISEcp1B transposase䋬intI1䋻Class I integrase䋬aacA4䋻aminoglycoside (6)`-N-acetyltransferase䋬aadA2䋻aminoglycoside
adenyltransferase䋬tnp䋻Transposase of IS91 family
㧙 㧙
㧨⠨ኤ㧪
2012 ᐕߦ Shigemoto ࠄ 2)߇ K. pneumoniae ߦ߅޿ߡ blaCTX-M-2 ߣ blaIMP-6 ࠍࠦ࡯࠼ߔࠆࡊ࡜ࠬࡒ
࠼ pKPI-6 ࠍႎ๔ߒߡ޿ࠆ㧚੹࿁ E. coli NM5759 ߆ࠄන㔌ߒߚ p-NM5759-JM ߩ blaCTX-M-2 ߣ
blaIMP-6 ๟࿐ߩႮၮ㈩೉ߪ pKPI-6 ߣߩ⋧หᕈ߇㜞ߊ㧔blaCTX-M-2 ๟ㄝ 4505bpЈ⋧หᕈ 98%㧘
blaIMP-6 ๟ㄝ 4594bpЈ⋧หᕈ 90%㧕pKPI-6 ߣห৻ߩࡊ࡜ࠬࡒ࠼ߩน⢻ᕈ߇␜ໂߐࠇߚ㧚߹ߚ㧘Yano
ࠄ 3)ߪ㧘PCR ᴺߦߡ IMP-1 ㆮવሶ㓁ᕈߢ޽ߞߚ E. coli 54 ᩣߩ߁ߜ㧘Ⴧ᏷↥‛ߩႮၮ㈩೉ࠍ⺞ߴߚ
ߣߎࠈ㧘49 ᩣ߇ IMP-6 ࠲ࠗࡊߢ޽ࠅ㧘IMP-6 ㆮવሶࠍ଻᦭ߔࠆᩣߩߔߴߡ߇ CTX-M ㆮવሶ㓁ᕈ
ߢ޽ߞߚߣႎ๔ߒߡ޿ࠆߎߣ߆ࠄ㧘
CTX-M ߣ IMP-6 ߩㆮવሶࠍࠦ࡯࠼ߔࠆห᭽ߩࡊ࡜ࠬࡒ࠼߇㧘
⒳ዻࠍ⿥߃ߡᏒਛߦ᜛ᢔߒߡ޿ࠆน⢻ᕈ߇ෂᗋߐࠇࠆ㧚
㧨߹ߣ߼㧪
੹࿁ᚒ‫ߪޘ‬㧘ESBL ߅ࠃ߮ MBL ࠍหᤨߦ↥↢ߔࠆ E. coli NM5759 ߦߟ޿ߡ㧘⠴ᕈㆮવሶߩሽ࿷
ㇱ૏߅ࠃ߮ㆮવ⊛ߥᕈ⾰ߦߟ޿ߡ⺞ߴߚ㧚E. coli NM5759 ߪዋߥߊߣ߽㧟⒳㘃ߩࠨࠗ࠭ߩ⇣ߥࠆ
ࡊ࡜ࠬࡒ࠼ࠍ଻᦭ߒߡ߅ࠅ㧘ᦨ߽ࠨࠗ࠭ߩᄢ߈޿ p-NM5759-JM ߦਔᣇߩ⠴ᕈㆮવሶ߇ሽ࿷ߒߡ
޿ߚ㧚
㧨ෳ⠨ᢥ₂㧪
1) Sanger,F., Nicklen,S.,and Coulson,A.R.: DNA sequencing with chain-terminating inhibitors.Proc.
Natl.Acad. Sci. USA.74:5463–5467,1977.
2) Shigemoto,N.,Kuwahara,R.,Kayama,S.,Shimizu,W.,Onodera,M.,Yokozaki,M.,Hisatsune,J.,Kato,F.,Oh
ge,H. and Sugai,M.:Emergence in Japan of an imipenem-susceptible, meropenem- resistant
Klebsiella pneumoniae carrying blaIMP-6. Diagnostic Microbiology and Infec-tious Disease.
72 :109–112,2012.
3) Yano,H.,Ogawa,M.,Endo,S.,Kakuta,R.,Kanamori,H.,Inomata,S.,Ishibashi,N.,Aoyagi,T.,Hatta,M.,Gu,
Y.,Yam-ada,M.,Tokuda,K.,Kunishima,H.,Kitagawa,M.,Hirakata,Y. and Kaku,M.: High frequency o
f IMP-6 among clinical isolates of metallo--lactamase-producing Escherichia coli in Japan.
Antimicrobial A-gents and Chemotherapy.56:4554-4555, 2012.
㧨⚻⾌૶ㅜ᣿⚦㧪
ㆮવሶ⸃ᨆᖱႎಣℂ࠰ࡈ࠻࠙ࠚࠕ)'0'6;:8GT ౞
౞
੐ോ▤ℂᚻᢙᢱ
౞
ว ⸘
એ਄
㧙 㧙